Inhibitory Effect of Jingui Shenqi Pills on Glucocorticoid-Enhanced Axial Length Elongation in Experimentally Myopic Guinea Pigs
Back to article page
Original Article|Updated:2023-11-23
|
Inhibitory Effect of Jingui Shenqi Pills on Glucocorticoid-Enhanced Axial Length Elongation in Experimentally Myopic Guinea Pigs
Chinese Journal of Integrative MedicineVol. 29, Issue 11, Pages: 989-997(2023)
Affiliations:
1.Department of Ophthalmology and Optometry, Shandong University of Traditional Chinese Medicine, Jinan (250014), China
2.Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine, Jinan (250002), China
3.Shandong Province Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Therapy of Ocular Disease; Shandong Academy of Eye Disease Prevention and Therapy, Jinan (250002), China
JIANG Qian, JIANG Wen-jun, YANG Cheng-xiu, et al. Inhibitory Effect of Jingui Shenqi Pills on Glucocorticoid-Enhanced Axial Length Elongation in Experimentally Myopic Guinea Pigs. [J]. Chinese Journal of Integrative Medicine 29(11):989-997(2023)
DOI:
JIANG Qian, JIANG Wen-jun, YANG Cheng-xiu, et al. Inhibitory Effect of Jingui Shenqi Pills on Glucocorticoid-Enhanced Axial Length Elongation in Experimentally Myopic Guinea Pigs. [J]. Chinese Journal of Integrative Medicine 29(11):989-997(2023) DOI: 10.1007/s11655-023-3738-x.
Inhibitory Effect of Jingui Shenqi Pills on Glucocorticoid-Enhanced Axial Length Elongation in Experimentally Myopic Guinea Pigs
摘要
Abstract
Objective:
2
To explore the underlying mechanism of inhibition by Jingui Shenqi Pills (JGSQP) on glucocorticoid-enhanced axial length elongation in experimental lens-induced myopia (LIM) guinea pigs.
Methods:
2
Sixty 2-week old male guinea pigs were randomly divided into 4 groups with 15 guinea pigs in each group
according to the random numbers generated by SPSS software: control
LIM
saline and JGSQP groups. The control group includes animals with no treatment
while the guinea pigs in the other 3 groups received lens-induced myopization on the right eyes throughout the experiment (for 8 weeks). The saline and JGSQP groups were given daily intraperitoneal injections of 10 mg/kg hydrocortisone for 2 consecutive weeks at the same time
and then orally administered either saline or JGSQP [13.5 g/(kg • d) for 6 consecutive weeks. Body weight
anal temperature and animal appearance were observed and recorded to evaluate the GC-associated symptoms. The ocular parameters
including refraction and axial length
were measured by streak retinoscopy and A-scan ultrasonography
respectively. The levels of plasma hormones associated with the hypothalamic-pituitary-adrenal axis (HPAA)
including free triiodothyronine
free thyroxine
estradiol and testosterone
were measured by radioimmunoassay
and cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate were measured by enzyme-linked immunosorbent assay. In addition
the mRNA and protein expressions of retinal amphiregulin (AREG) was measured by quantitative real-time polymerase chain reaction and Western blotting
respectively.
Results:
2
JGSQP effectively increased body weight and anal temperature
improved animal appearance and suppressed axial length elongation in glucocorticoid- enhanced myopic guinea pigs with normalization of 4 HPAA-associated plasma hormones (all
P
<
0.05). The plasma level of cAMP was significantly increased
whereas the plasma level of cGMP and the mRNA and protein expressions of retinal AREG were decreased after treatment with JGSQP (all
P
<
0.05).
Conclusion:
2
JGSQP exhibited a significant inhibitory effect on axial length elongation with decreased expression of AREG in the retina
and normalized 4 HPAA-associated plasma hormones and the expression of cAMP and cGMP in GC-enhanced myopic guinea pigs.